Assyro AI

FDA Orange Book · active-ingredient family

Aspirin; meprobamate

Aspirin; meprobamate is approved as 1 brand and 4 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:EQUAGESIC · NDA 011702

1

Brand (NDA)

4

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
EQUAGESICSUN PHARM INDUSTRIESNDA 011702Dec 29, 1983

Generic (ANDA) products (4)

ProductApplicantApplicationTEApproved
MEPRO-ASPIRINSANDOZANDA 089127Mar 02, 1987
MEPROBAMATE AND ASPIRINPAR PHARMANDA 089126Aug 19, 1986
Q-GESICQUANTUM PHARMICSANDA 088740Jun 01, 1984
MICRAININMEDPOINTE PHARM HLCANDA 084978Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Aspirin; meprobamate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.